Jason Thompson - INDIVIOR PLC VP Relations
Insider
Jason Thompson is VP Relations of INDIVIOR PLC ADR
| Phone | 804 379 1090 |
| Web | https://www.indivior.com |
INDIVIOR PLC Management Efficiency
The company has return on total asset (ROA) of 0.0697 % which means that it generated a profit of $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8557 %, meaning that it generated $0.8557 on every $100 dollars invested by stockholders. INDIVIOR PLC's management efficiency ratios could be used to measure how well INDIVIOR PLC manages its routine affairs as well as how well it operates its assets and liabilities.INDIVIOR PLC ADR has accumulated 239 M in total debt with debt to equity ratio (D/E) of 1.22, which is about average as compared to similar companies. INDIVIOR PLC ADR has a current ratio of 1.67, which is within standard range for the sector. Debt can assist INDIVIOR PLC until it has trouble settling it off, either with new capital or with free cash flow. So, INDIVIOR PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like INDIVIOR PLC ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for INDIVIOR to invest in growth at high rates of return. When we think about INDIVIOR PLC's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard MD | Collegium Pharmaceutical | 64 | |
| Matthew Lowell | Alpha Teknova | 55 | |
| Jacob MBA | Amphastar P | 50 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| R Hoover | Elanco Animal Health | 75 | |
| Roy MD | Pacira BioSciences, | 62 | |
| Benjamin MBA | Esperion Therapeutics | 39 | |
| Cecilia Coupland | Orexo AB | 47 | |
| Damon Terrill | Alpha Teknova | 53 | |
| Paul Herendeen | Elanco Animal Health | 65 | |
| Zorina Pitkin | Organogenesis Holdings | N/A | |
| Jude Onyia | Neurocrine Biosciences | 61 | |
| Ziping Luo | Amphastar P | 75 | |
| BA Esq | Organogenesis Holdings | 55 | |
| Racquel Mason | Elanco Animal Health | 50 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Dennis Urbaniak | Orexo AB | 54 | |
| Betty Swartz | Esperion Therapeutics | N/A | |
| Adalmario Couto | Hypera SA | N/A | |
| MD FACC | Esperion Therapeutics | 59 | |
| Fredrik Jarrsten | Orexo AB | 56 | |
Management Performance
| Return On Equity | 0.86 | |||
| Return On Asset | 0.0697 |
INDIVIOR PLC ADR Leadership Team
Elected by the shareholders, the INDIVIOR PLC's board of directors comprises two types of representatives: INDIVIOR PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INDIVIOR. The board's role is to monitor INDIVIOR PLC's management team and ensure that shareholders' interests are well served. INDIVIOR PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INDIVIOR PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Fogle, Chief Human Resource Officer | ||
| Nina DeLorenzo, Chief Officer | ||
| Jeffrey Burris, Chief Officer | ||
| Jason Thompson, VP Relations | ||
| Christian Heidbreder, Chief Scientific Officer | ||
| Richard Simkin, Chief Commercial and Strategy Officer | ||
| Ryan Preblick, CFO Director | ||
| Mark Crossley, CFO, Director | ||
| Hillel West, Chief Officer | ||
| Cynthia Cetani, Chief Officer |
INDIVIOR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is INDIVIOR PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.86 | |||
| Return On Asset | 0.0697 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 2.39 B | |||
| Shares Outstanding | 136.19 M | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Earning | 37.60 X | |||
| Price To Book | 13.75 X | |||
| Price To Sales | 3.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in INDIVIOR Pink Sheet
If you are still planning to invest in INDIVIOR PLC ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INDIVIOR PLC's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |